SAG
RNAM

SageView Advisory Group’s Avidity Biosciences RNAM Stock Holding History

SageView Advisory Group’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.25K Buy
+45
New +$2.91K ﹤0.01% 2088

Other funds holding RNAM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SageView Advisory Group's RNAM Position: Q4 2025 in Review

SageView Advisory Group opened a new position in Avidity Biosciences (RNAM) in Q4 2025: 45 shares worth $3.25K. The stake represents ﹤0.01% of the portfolio and ranks #2088 among its holdings.

343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

  • SageView Advisory Group held 45 shares of Avidity Biosciences worth $3.25K as of Q4 2025.
  • Avidity Biosciences was a new SageView Advisory Group position in Q4 2025.
  • Avidity Biosciences made up ﹤0.01% of SageView Advisory Group's portfolio in Q4 2025, its #2088 holding.
  • 343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.